Evaluation of pharmaceutical industry-led access programmes: a standardised framework

Area of Science:

• Health Economics
• Pharmaceutical Policy
• Global Health

Background:

• Pharmaceutical industry-led access programs are expanding globally.
• There is a need for standardized methods to evaluate these programs effectively.
• Current evaluation approaches lack consistency, hindering cross-program learning.

Purpose of the Study:

• To introduce a novel, standardized framework for evaluating pharmaceutical industry-led access programs.
• To provide a consistent methodology for assessing program strategies and impact.
• To facilitate better understanding and reporting of access program performance.

Main Methods:

• Development of a taxonomy categorizing 11 distinct access program strategies.
• Creation of strategy-specific logic models outlining potential impact pathways.
• Identification of measurement indicators with associated metadata for each concept.

Main Results:

• The framework comprises a taxonomy, logic models, and measurement indicators.
• Logic models illustrate potential program impact pathways.
• Measurement indicators include definitions, measurement details, and data sources.

Conclusions:

• The proposed framework establishes a common language for reporting on industry-led access programs.
• Widespread adoption can enhance shared learning on effective strategies and best practices.
• This standardization is crucial for optimizing global medicine access initiatives.